Insights & Resources – COD Research – Designing Therapies For Future

The Evolution of PRO Collection: From Paper Diaries to ePRO Systems

Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial

Biometrics

Clinical Services

CT Quality Assurance

Medical Affairs

Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment

Strategic Planning for Patient Recruitment

EMA
FDA
MHRA

Digitalisation and artificial Intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2026, 09:30 (CET) to 19 November 2026, 17:30 (CET)
Source: EMA Published on 2026-08-13
Presentation - Challenges and opportunities in medicines and medical devices development
Source: EMA Published on 2026-08-13
Presentation - Adiposity: The gateway to cardiometabolic diseases (L. Fábryová)
Source: EMA Published on 2026-08-13
Presentation - Cardiometabolic diseases: Tackling the unmet need in CV risk reduction (F. Giorgino)
Source: EMA Published on 2026-08-13
Presentation - Cardiometabolic diseases: tackling the unmet need in cardiovascular risk reduction (J. Nabais)
Source: EMA Published on 2026-08-13
Presentation - Global collaboration in cardiovascular medicine development (M. Inoue)
Source: EMA Published on 2026-08-13

Read More